Novo Nordisk Canada Inc.
Registration:
17
of
19
(2023-11-01
to
2024-04-01)
Policies or Program
- Advocate for the establishment of public-private partnerships to support chronic disease prevention.
- Advocate for the implementation of a federal diabetes and obesity strategy.
- Support the establishment of a life sciences strategy in Canada
Regulation
- Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians
- Date Modified: